Page last updated: 2024-10-30

mecamylamine and Pre-Eclampsia

mecamylamine has been researched along with Pre-Eclampsia in 2 studies

Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.

Pre-Eclampsia: A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
AGAR, H1
BARRETT, CT1
EXLEY, KA1
URANGAIMAZ, FA2
TONNELIER, E1
KLAUER, D1
CHEKERDEMIAN, M1

Other Studies

2 other studies available for mecamylamine and Pre-Eclampsia

ArticleYear
Experiences with mecamylamine in hypertensive complications of pregnancy.
    The Journal of obstetrics and gynaecology of the British Empire, 1958, Volume: 65, Issue:3

    Topics: Autonomic Agents; Eclampsia; Female; Humans; Hypertension; Mecamylamine; Pre-Eclampsia; Pregnancy; P

1958
[THERAPEUTICS OF ARTERIAL HYPERTENSION IN PREGNANCY].
    Revista de la Asociacion Medica Argentina, 1964, Volume: 78

    Topics: Female; Guanethidine; Hibernation; Humans; Hydralazine; Hypertension; Hypothermia, Induced; Maternal

1964